Improved formulations of nicotinamide riboside: A promising treatment for age-related disorders

an array of samples of nicotinamide riboside

Nicotinamide adenine dinucleotide (NAD+) is a co-enzyme involved in fundamental metabolic roles. Its levels decrease with aging, causing the development of age-related pathologies. NAD+ levels can be replenished by the intake of nicotinamide riboside (NR), a vitamin B3 analogue, which is naturally converted to NAD+. Regular use of NR supplementation is associated with improved outcomes in several cardiovascular, neurodegenerative, and […]

Read More…

High performing monomers and polymers from plant oils

a field of yellow rape

We often think of fossils fuels as a source of energy, but one of the key uses of fossil fuels is as a starting point for the synthesis of new chemical compounds. These range from plastics to pharmaceutical products. In recent years, there has been a push to move to more sustainable chemical feedstocks. Professor Andriy Voronov at North Dakota […]

Read More…

Novel mouse models shed light on role of omega-6/omega-3 imbalance in chronic disease

Dr Kang's research suggests that a diet high in omega-3 and low in omega-6 helps prevent many chronic diseases.

The link between two classes of essential fatty acids – omega-3 and omega-6 – and health has, until now, been unclear. This is partly because it has been difficult for researchers to define exactly what each does in the body. To address this problem, Dr Jing X. Kang of Massachusetts General Hospital and Harvard Medical School, USA, developed novel strains […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION